Cost of non-infectious co-morbidities in patients with HIV
Giovanni Guaraldi(University of Modena and Reggio Emilia), Frank J. Palella(Northwestern University), Marianna Menozzi(Azienda Ospedaliero-Universitaria di Modena), Federica Carli(Istituto di Fisiologia Clinica), Elisa Rossi(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Gabriella Orlando(University of Modena and Reggio Emilia), P Bagni(University of Modena and Reggio Emilia), G. Zoboli, A. L. Berti, Stefano Zona(University of Modena and Reggio Emilia)
Dove Medical Press (Taylor and Francis Group)
January 1, 2011
Cited by 0
Related Papers
Premature Age-Related Comorbidities Among HIV-Infected Persons Compared With the General Population
|Clinical Infectious Diseases|2011|1.3k
Tocilizumab in patients with severe COVID-19: a retrospective cohort study
|The Lancet Rheumatology|2020|998
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
|Nature Communications|2020|846
Weight gain among treatment‐naïve persons with HIV starting integrase inhibitors compared to non‐nucleoside reverse transcriptase inhibitors or protease inhibitors in a large observational cohort in the United States and Canada
|Journal of the International AIDS Society|2020|242
Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States
|Clinical Infectious Diseases|2017|179